Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice
出版年份 2015 全文链接
标题
Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 12, Pages e0144064
出版商
Public Library of Science (PLoS)
发表日期
2015-12-04
DOI
10.1371/journal.pone.0144064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice
- (2015) Yan-ju Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Induction of Energy Expenditure by Sitagliptin Is Dependent on GLP-1 Receptor
- (2015) Felicia Goldsmith et al. PLoS One
- PGC1-α over-expression prevents metabolic alterations and soleus muscle atrophy in hindlimb unloaded mice
- (2014) Jessica Cannavino et al. JOURNAL OF PHYSIOLOGY-LONDON
- Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
- (2013) Brian Zambrowicz et al. CLINICAL THERAPEUTICS
- The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment
- (2013) A. Flint et al. DIABETES OBESITY & METABOLISM
- The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice
- (2013) Sayaka Fukuda-Tsuru et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Emerging gliptins for type 2 diabetes
- (2013) Avivit Cahn et al. EXPERT OPINION ON EMERGING DRUGS
- Adipose tissue browning and metabolic health
- (2013) Alexander Bartelt et al. Nature Reviews Endocrinology
- Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
- (2013) Claes-Göran Ostenson et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism
- (2012) Kikuo Yo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives
- (2012) Patrick C. Even et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Alterations in energy balance following exenatide administration
- (2012) David P. Bradley et al. Applied Physiology Nutrition and Metabolism
- Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
- (2012) S. Hamamoto et al. DIABETES OBESITY & METABOLISM
- Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
- (2012) Michael Horowitz et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity
- (2012) Clinton T. Elfers et al. Hormone Research in Paediatrics
- Relative shrinkage of adipocytes by paraffin in proportion to plastic embedding in human adipose tissue before and after weight loss
- (2012) Sanne P.M. Verhoef et al. Obesity Research & Clinical Practice
- Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation
- (2012) C. Guillet et al. Obesity Reviews
- Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression
- (2012) Joana Rosmaninho-Salgado et al. PEPTIDES
- Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
- (2012) Matthias Kern et al. PLoS One
- Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
- (2011) Heung Jae Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
- (2011) Joan Vendrell et al. ENDOCRINOLOGY
- A review of gliptins in 2011
- (2011) André J Scheen EXPERT OPINION ON PHARMACOTHERAPY
- Regulation of Adipocyte Formation by GLP-1/GLP-1R Signaling
- (2011) Tenagne Delessa Challa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes
- (2011) Mi-Kyung Kim et al. LIFE SCIENCES
- Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK
- (2010) Mandeep P. Gaidhu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats
- (2010) Yasushi Kirino et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
- (2010) A. D. Dobrian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis
- (2010) Jae Min Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Perilipin Overexpression in White Adipose Tissue Induces a Brown Fat-Like Phenotype
- (2010) Takashi Sawada et al. PLoS One
- Increased Plasma Dipeptidyl Peptidase IV (DPP IV) Activity and Decreased DPP IV Activity of Visceral But Not Subcutaneous Adipose Tissue in Impaired Glucose Tolerance Rats Induced by High-Fat or High-Sucrose Diet
- (2009) Yasushi Kirino et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue
- (2009) K. Kos et al. DIABETES OBESITY & METABOLISM
- Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
- (2009) James Mu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
- (2009) M-H Son et al. INTERNATIONAL JOURNAL OF OBESITY
- Conjugated Linoleic Acid Induces Uncoupling Protein 1 in White Adipose Tissue of ob/ob Mice
- (2009) Angela A. Wendel et al. LIPIDS
- Dipeptidyl-Peptidase-IV Inhibition Augments Postprandial Lipid Mobilization and Oxidation in Type 2 Diabetic Patients
- (2008) Michael Boschmann et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL
- (2008) Mandeep P. Gaidhu et al. JOURNAL OF LIPID RESEARCH
- Chronic Treatment with the Dipeptidyl Peptidase-4 Inhibitor BI 1356 [(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione] Increases Basal Glucagon-Like Peptide-1 and Improves Glycemic Control in Diabetic Rodent Models
- (2008) L. Thomas et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started